abstract |
The present invention relates to the field of immunity against coronavirus. The present invention provides vectorized antigens derived from coronaviruses that elicit an immune response against coronaviruses. Accordingly, the present invention provides an active ingredient that is a live attenuated recombinant measles virus expressing a coronavirus antigen, and induces immunity, in particular protective immunity against SARS-CoV-2 strains and advantageously broad protective immunity against various coronavirus strains. It relates to its use for |